-
-
Pharma & Human Health -
Finance -
Finance -
Editor's Choice
Editor’s Choice
Editor's Choice
Modulating the Preterm Gut Microbiota: An Interview with Dr Lindsay Hall
Dr Lindsay Hall of the Quadram Institute talks to us about the preterm infant gut microbiota and its modulation.
Editor's Choice
Pharmabiotics 2019 Wrap Up: The Latest in Microbiotic Medicinal Products
This 5th Pharmabiotics Conference Edition, hosted by the Pharmabiotic Research Institute, took place Mid-March in Paris and peaked as the most successful to date, with over 190 delegates attending over the 2-day event. As in […]
Editor's Choice
5-minute Microbiome Science Roundup: April 2019
This month’s 5-minute microbiome science roundup includes some important papers published this month related to both health and disease. The two colorectal cancer microbiome-related papers published in Nature are a sign that the field is beginning […]
Preserve Sample Quality And Streamline Sample Processing
In Case you Missed it:
Finance
Vedanta Biosciences Key Microbiome Patent Upheld in European Opposition Proceedings
Vedanta Biosciences, a clinical-stage company developing a new category of therapies for immune-mediated diseases based on rationally-defined consortia of human microbiome-derived bacteria, announced that the Opposition Division of the European Patent Office has upheld Vedanta’s […]
Editor's Choice
Pharmabiotics 2019 Wrap Up: The Latest in Microbiotic Medicinal Products
This 5th Pharmabiotics Conference Edition, hosted by the Pharmabiotic Research Institute, took place Mid-March in Paris and peaked as the most successful to date, with over 190 delegates attending over the 2-day event. As in […]
Finance
Seres Therapeutics First Quarter Financial Results and Clinical Pipeline Progress
Highlights Four significant microbiome program milestones expected during 2020, including readouts from two late-stage development programs SER-287 Fast Track designation obtained for active mild-to-moderate ulcerative colitis; Phase 2b study enrollment expected to be completed by […]
Editor's Choice
5-minute Microbiome Science Roundup: April 2019
This month’s 5-minute microbiome science roundup includes some important papers published this month related to both health and disease. The two colorectal cancer microbiome-related papers published in Nature are a sign that the field is beginning […]
Pharma & Human Health
4D Pharma Clinical Update on MRx0518 Oncology Programmes
The first patient participating in the combination phase I/II study of MRx0518 and *KEYTRUDA® in collaboration with Merck & Co., Inc., Kenilworth, NJ., USA and 4D’s strategic collaboration with MD Anderson has completed Cycle 1 […]
